Related references
Note: Only part of the references are listed.Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
Federico Verde et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)
Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
Eleonora Colombo et al.
JOURNAL OF NEUROLOGY (2023)
Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis
Alessio Maranzano et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis
Yuri Matteo Falzone et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
Amyotrophic lateral sclerosis
Eva L. Feldman et al.
LANCET (2022)
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Timothy M. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years
Joel Simren et al.
BRAIN COMMUNICATIONS (2022)
Respiratory parameters on diagnostic sleep studies predict survival in patients with amyotrophic lateral sclerosis
Markus Engel et al.
JOURNAL OF NEUROLOGY (2021)
Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders
Barbara Poletti et al.
NEUROLOGY (2021)
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Federico Verde et al.
FRONTIERS IN NEUROSCIENCE (2021)
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis
E. Thouvenot et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
Samir Abu-Rumeileh et al.
JOURNAL OF NEUROLOGY (2020)
Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis
Colin Quinn et al.
MUSCLE & NERVE (2020)
Neurofilaments: neurobiological foundations for biomarker applications
Arie R. Gafson et al.
BRAIN (2020)
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar et al.
NEUROLOGY (2020)
Renal function is associated with blood neurofilament light chain level in older adults
Shoshin Akamine et al.
SCIENTIFIC REPORTS (2020)
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
B. Gille et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Assessing anxiety and its correlates in amyotrophic lateral sclerosis: The state-trait anxiety inventory
Mattia Siciliano et al.
MUSCLE & NERVE (2019)
Neurochemical biomarkers in amyotrophic lateral sclerosis
Federico Verde et al.
CURRENT OPINION IN NEUROLOGY (2019)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
Emily Feneberg et al.
NEUROLOGY (2018)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Michael J. Strong et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis Neurofilament Light Chain Levels in Definite Subtypes of Disease
Alessandra Gaiani et al.
JAMA NEUROLOGY (2017)
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Petra Steinacker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis
Matthew S. Devine et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)
Barbara Poletti et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores
Silvia Conti et al.
NEUROLOGICAL SCIENCES (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine A Population-Based Study
Adriano Chio et al.
JAMA NEUROLOGY (2014)
A proposed staging system for amyotrophic lateral sclerosis
Jose C. Roche et al.
BRAIN (2012)
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Adriano Chio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease
A. Alberici et al.
NEUROLOGICAL SCIENCES (2007)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)